Language menu:
GLUSCAN®
GLUSCAN® is the AAA brand name for [18F]FDG (Fluoro Deoxy Glucose)
FDG is the most widely used PET tracer. In the literature*, FDG is used to assess glucose metabolism in the brain (Alzheimer’s disease, dementia, epilepsy, brain trauma, Huntington disease, cerebrovascular disorders, brain tumors, schizophrenia, and mood disorders), cancer (lung, colorectal, esophageal, head and neck, breast and thyroid carcinoma, melanoma, lymphoma), cardiovascular diseases (myocardial viability and atherosclerosis), and infectious, autoimmune, and inflammatory diseases (orthopedic infections, osteomyelitis, ileitis, sarcoidosis, rheumatologic disease, and vasculitis).
*Some of the cited uses are not validated in the GLUSCAN® marketing authorisation. Please refer to the SPC of the product.
GLUSCAN® is registered in France, Italy, Switzerland, Belgium and Luxembourg.
Products category